ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
阿里阿德
23.99
0.0000
成交量：
- -
成交額：
- -
市值：
46.59億
市盈率：
-133.28
高：
23.99
開：
23.99
低：
23.99
收：
23.99
52周最高：
23.99
52周最低：
23.99
股本：
1.94億
流通股本：
1.70億
量比：
- -
換手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
-0.1800
淨資產收益率：
--
總資產收益率：
--
市淨率：
-100.52
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
阿里阿德
交易所：
NASDAQ
成立時間：
- -
員工人數：
- -
公司地址：
- -
官網：
http://www.ariad.com
郵編：
- -
電話：
- -
傳真：
- -
簡介：
ARIAD Pharmaceuticals, Inc.的前景是通過具有突破性的藥物治療癌症患者。該公司致力於發現、開發和推廣小分子藥物來治療癌症患者，滿足患者最迫切的醫療需求——目前無法治療的侵略性癌症。該公司的目標是建立一個完全集成的腫瘤學公司。該公司目前有三個正在開發中的候選產品。白血病藥物Ponatinib正處於血液腫瘤患者臨床試驗的第一階段和第二階段，包括慢性髓性白血病和費城陽性急性淋巴細胞白血病的臨床試驗。藥物AP26113正處於治療晚期實體腫瘤的臨床試驗的第一階段和第二階段。藥物Ridaforolimus正處於研究不同類型癌症患者的多個臨床試驗中。根據附註2所述的許可協議的條款，默克股份有限公司（ Merck, Sharpe & Dohme Corp. ）負責藥物Ridaforolimus相關的開發、製造和推廣活動。除了公司的主導發展計劃，該公司重點放在分子靶向癌症細胞信號通路的小分子療法的針對性藥物研發項目。該公司於1991年4月在特拉華州註冊成立。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ARIA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"ARIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARIA\",,,,,undefined,":{"symbol":"ARIA","market":"US","secType":"STK","nameCN":"阿里阿德","latestPrice":23.99,"timestamp":1774036800000,"preClose":23.99,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":169700000,"shares":194200862,"eps":-0.18,"marketStatus":"休市中","change":0,"latestTime":"03-20 16:00:00 EDT","open":23.99,"high":23.99,"low":23.99,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.18,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":23.99,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARIA\",,,,,undefined,":{"symbol":"ARIA","floatShares":169700000,"roa":"--","roe":"--","lyrEps":0,"shares":194200862,"dividePrice":0,"high":23.99,"amplitude":0,"preClose":23.99,"low":23.99,"week52Low":23.99,"pbRate":"-100.52","week52High":23.99,"institutionHeld":0.5771,"latestPrice":23.99,"eps":-0.18,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.18,"open":23.99,"prevYearClose":23.99,"prevWeekClose":23.99,"prevMonthClose":23.99,"prevQuarterClose":23.99,"fiveDayClose":23.99,"twentyDayClose":23.99,"sixtyDayClose":23.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARIA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-11-07","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":-0.19,"name":null,"time":"盤前","type":"earning","dateTimestamp":1478494800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-07-28","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":0.57,"name":null,"time":"盤前","type":"earning","dateTimestamp":1469678400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-05-10","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":-0.28,"name":null,"time":"盤前","type":"earning","dateTimestamp":1462852800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-02-23","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":-0.28,"name":null,"time":"盤前","type":"earning","dateTimestamp":1456203600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2015-11-03","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":-0.2,"name":null,"time":"盤前","type":"earning","dateTimestamp":1446526800000,"reportTimeType":"pre","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARIA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.ariad.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"ARIAD Pharmaceuticals, Inc.的前景是通過具有突破性的藥物治療癌症患者。該公司致力於發現、開發和推廣小分子藥物來治療癌症患者，滿足患者最迫切的醫療需求——目前無法治療的侵略性癌症。該公司的目標是建立一個完全集成的腫瘤學公司。該公司目前有三個正在開發中的候選產品。白血病藥物Ponatinib正處於血液腫瘤患者臨床試驗的第一階段和第二階段，包括慢性髓性白血病和費城陽性急性淋巴細胞白血病的臨床試驗。藥物AP26113正處於治療晚期實體腫瘤的臨床試驗的第一階段和第二階段。藥物Ridaforolimus正處於研究不同類型癌症患者的多個臨床試驗中。根據附註2所述的許可協議的條款，默克股份有限公司（ Merck, Sharpe & Dohme Corp. ）負責藥物Ridaforolimus相關的開發、製造和推廣活動。除了公司的主導發展計劃，該公司重點放在分子靶向癌症細胞信號通路的小分子療法的針對性藥物研發項目。該公司於1991年4月在特拉華州註冊成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.517241,"avgChangeRate":0.16958},{"month":2,"riseRate":0.448276,"avgChangeRate":0.086058},{"month":3,"riseRate":0.392857,"avgChangeRate":-0.009238},{"month":4,"riseRate":0.464286,"avgChangeRate":0.03145},{"month":5,"riseRate":0.428571,"avgChangeRate":0.027992},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.004208},{"month":7,"riseRate":0.321429,"avgChangeRate":-0.004919},{"month":8,"riseRate":0.464286,"avgChangeRate":0.016814},{"month":9,"riseRate":0.392857,"avgChangeRate":0.01499},{"month":10,"riseRate":0.310345,"avgChangeRate":-0.021336},{"month":11,"riseRate":0.482759,"avgChangeRate":0.074931},{"month":12,"riseRate":0.310345,"avgChangeRate":0.023298}],"exchange":"NASDAQ","name":"阿里阿德","nameEN":"ARIAD Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ARIA\",market:\"US\",,,undefined,":null}}